Stock based compensation (Tables)

12 Months Ended

Jun. 28, 2026

Share-Based Payment Arrangement [Abstract]

Schedule of Stock-Based Payment Compensation Expense

The amounts of stock-based compensation expense recognized within operating income (1) in the periods presented are as follows:


	Years Ended
	June 28, 2026		June 29, 2025		June 30, 2024

	(in thousands)

Stock options	$	2,634	$	4,729	$	4,422
Restricted stock awards	8,622		7,162		6,266
Total	11,256		11,891		10,688

(1)Stock-based compensation expense has not been allocated among business segments, but is reflected as part of Corporate overhead (See Note 17 - Business segments for details).

Schedule of Stock-Based Payment Compensation Expense by Operating Expense Line Item

Stock-based compensation expense is recorded within the following line items of operating expenses:


	Years Ended
	June 28, 2026		June 29, 2025		June 30, 2024

	(in thousands)

Marketing and sales	$	5,178	$	5,470	$	4,916
Technology and development	901		951		855
General and administrative	5,177		5,470		4,917
Total	$	11,256	$	11,891	$	10,688

Schedule of Valuation Assumptions for Stock Options

The weighted average fair value of stock options on the date of grant, and the assumptions used to estimate the fair value of the stock options using the Black-Scholes option valuation model, were as follows:


	Years Ended
	June 28, 2026	June 29, 2025	June 30, 2024
	(1)
Weighted average fair value of options granted	n/a	$3.25	$6.09
Expected volatility	n/a	58%	56%
Expected life (in years)	n/a	7	7
Risk-free interest rate	n/a	4.3%	3.9%
Expected dividend yield	n/a	—%	—%

(1) No options were granted during the fiscal year ended June 28, 2026.

Schedule of Stock Option Activity

The following table summarizes stock option activity during the year ended June 28, 2026:


	Options	Weighted Average Exercise Price		Weighted Average Remaining Contractual Term	Aggregate Intrinsic Value
				(in years)	(in thousands)
Outstanding beginning of period	3,329,718	$	8.59
Granted	—	$	—
Exercised	—	$	—
Forfeited/Expired	(445,896)	$	8.59
Outstanding end of period	2,883,822	$	8.59	6.97	$	—

Exercisable at June 28, 2026	1,938,093	$	8.71	6.48	$	—

Schedule of Nonvested Restricted Stock Activity

The following table summarizes the activity of non-vested restricted stock during the year ended June 28, 2026:


	Shares	Weighted Average Grant Date Fair Value

Non-vested – beginning of period	2,110,656	$	9.98
Granted	4,420,017	$	4.70
Vested	(841,448)	$	7.75
Forfeited	(1,543,474)	$	5.88
Non-vested - end of period	4,145,751	$	6.33